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Role of differentially expressed
microRNA-139-5p in the regulation
of phenotypic internal anal
sphincter smooth muscle tone
Jagmohan Singh1, Ipsita Mohanty 1, Sankar Addya2, Benjamin Phillips3, Hwan Mee Yong4,
Steven S. An4, Raymond B. Penn5 & Satish Rattan1
The present study focused on the role of microRNA-139-5p (miRNA-139-5p) in the regulation of basal
tone in internal anal sphincter (IAS). Applying genome-wide miRNA microarrays on the phenotypically
distinct smooth muscle cells (SMCs) within the rat anorectrum, we identified miRNA-139-5p as
differentially expressed RNA repressor with highest expression in the purely phasic smooth muscle
of anococcygeus (ASM) vs. the truly tonic smooth muscle of IAS. This pattern of miRNA-139-5p
expression, previously shown to target ROCK2, was validated by target prediction using ingenuity
pathway (IPA) and by qPCR analyses. Immunoblotting, immunocytochemistry (ICC), and functional
assays using IAS tissues and cells subjected to overexpression/knockdown of miRNA-139-5p confirmed
the inverse relationship between miRNA-139-5p and ROCK2 expressions/IAS tone. Overexpression of
miRNA-139-5p caused a decrease, while knockdown by anti-miRNA-139-5p caused an increase in the
IAS tone; these tissue contractile responses were confirmed by single-cell contraction using magnetic
twisting cytometry (MTC). These findings suggest miRNA-139-5p is capable of significantly influencing
the phenotypic tonicity in smooth muscle via ROCK2: a lack of tone in ASM may be associated with the
suppression of ROCK2 by high expression of miRNA-139-5p, whereas basal IAS tone may be associated
with the persistence of ROCK2 due to low expression of miRNA-139-5p.
There is widespread agreement that basal tone in the internal anal sphincter (IAS) plays an important role in
a number of rectoanal motility disorders such as rectoanal incontinence1–5. There is an agreement as well that
unique myogenic properties of the smooth muscle cells (SMCs) in the IAS are primarily responsible for the
basal tone6–13. However, molecular mechanisms underlying the IAS tone are not well understood. In this regard,
humans as well as animal studies have shown that constitutively active and upregulated RhoA/ROCK is primarily responsible for the tone11–21. RhoA/ROCK leads to phosphorylation of myosin-binding subunit of myosin
light-chain phosphatase (MLCP) (p-MYPT1). The latter by inhibiting MLCP leads to increased phosphorylation
of the regulatory myosin light-chain (p-MLC20) which promotes smooth muscle tone19, 22, 23.
To further delineate the role of RhoA/ROCK in the genesis of IAS tone, systematic side-by-side functional and
molecular studies have been performed to compare adjoining smooth muscles within the rat anorectum. The IAS
by virtue of maintaining spontaneous tone is considered truly tonic and differs from rectal smooth muscle (RSM)
which is semi tonic as it has a mixture of tonic and phasic activities. In contrast, smooth muscle of anococcygeus
(ASM) has no tone, contracts briefly only following a stimulus, and is purely phasic11, 18, 24, 25. Numerous studies
have identified an important gradient in the expression levels of RhoA/ROCK in direct correlation with the phenotypic tonicity in these smooth muscles11, 18, 24, 25. However, the underlying molecular mechanisms for the high
expression of RhoA/ROCK in IAS vs. other smooth muscles are not known.
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MicroRNAs (miRNAs) generally considered to be RNA repressors, play an important role in evolution and
maintenance of the phenotypic characteristics of gastrointestinal tract smooth muscle by controlling the expression of smooth muscle-specific genes such as Kruppel like factor (KLF4), myocardin and serum response factor
(SRF)26–28. Likewise, studies in rat IAS and mouse stomach have shown that miRNA-133a downregulates RhoA in
aging- and diabetes-associated decrease in the respective smooth muscles’ contractility29, 30. It is well known that,
in the smooth muscle contractility, ROCK, specifically ROCK2 is an important downstream target of RhoA and
is expressed markedly higher in the tonic tissues such as the IAS11, 12, 31–33. However, to date there are no data to
discern molecular mechanism(s) underlying the differential expression of ROCK2 in determining fundamental
molecular differences between the tonic vs. the phasic smooth muscle phenotypes.
Considering the importance of miRNAs in regulating the expression of a number of genes in the smooth muscle26, 27, 29, 34, it was considered important to determine the role of miRNAs in the tonic vs. phasic smooth muscle.
Important insight into this question was provided by miRNA microarray analyses that identified miRNA-139–5p
to be one of the most differentially expressed miRNAs in three phenotypic smooth muscles with a gradient of
negative correlation with the levels of tone. Further literature and network analysis revealed that in different systems, miRNA-139-5p targets ROCK235, 36.
The main objective of the present study was to determine the role of miRNA-139-5p in the IAS tone in relation
to ROCK2. We first performed differential miRNA microarray analysis using diverse phenotypic smooth muscles: purely tonic (IAS), semi tonic (RSM), and purely phasic (ASM) smooth muscle. This comparison revealed
a gradient of expression of miRNA-139-5p with ASM > RSM > IAS, with miRNA-139-5p expression negatively
correlating with the known levels of tone in the tissues. We subsequently performed miRNA-139-5p gain- and
loss- of function studies to define the role of miRNA-139-5p in the ROCK2-dependent regulation of smooth
muscle phenotype. Our findings significantly advance current insight into the molecular regulation of the IAS
tone, with direct implications in a number of gastrointestinal and other systemic smooth muscle disorders.

Materials and Methods

Animals. Adult Sprague Dawley rats of 6 months age were used for the study and the experimental protocols
were approved by the Institutional Animal Care and Use Committee (IACUC) of Thomas Jefferson University.
Isolation of SMCs.

SMCs from IAS, RSM and ASM were isolated as per our previous studies37. Briefly, tissues were cut into 2 mm cubes and incubated in oxygenated Krebs physiological solution (KPS) containing 0.1%
collagenase and 0.01% trypsin inhibitor at 37 °C for 3 h. During incubation the buffer was replenished thrice after
1 h each, and at the end cells were centrifuged at 350 g for 10 min, followed by washing with fresh oxygenated KPS
without enzymes. Thereafter, mixture was centrifuged at 350 g for 10 min at room temperature and the cells in pellet were resuspended at the density of 3 × 104 cells/ml on collagen-coated plates in DMEM with 5% fetal bovine
serum, 5% penicillin streptomycin, 50 µg/ml gentamicin, 0.2 µg/ml amphotericin B, and 50 µg/ml sodium ascorbate in 100-mm tissue culture dishes (Corning) at 37 °C and 5% CO2 in an incubator with regulated humidity.

MicroRNA microarrays.

miRNA expression studies for IAS, RSM and ASM SMCs were performed as
described previously29, 38, 39. Briefly, miRNA fractions were isolated from the purified SMCs from the IAS, RSM and
ASM, by using miRVana miRNA Isolation kit following the manufacturer’s protocol (Life Technologies-Thermo
Fisher Scientific). Affymetrix GeneChip miRNA-1.0 Arrays (Affymetrix, Santa Clara, CA) were hybridized with
Flash Tag biotin-labeled total RNA (500 ng) from samples in 100 µl hybridization cocktail. Target denaturation
was performed at 99 °C for 5 min, and then 45 °C for 5 min, followed by hybridization at 48 °C for 18 h. Arrays
were washed and stained using Fluidic Station 450, and hybridization signals were amplified using antibody
amplification with goat IgG and anti-streptavidin biotinylated antibody, followed by scanning via Affymetrix
Gene Chip Scanner 3000 using Command Console Software. miRNA data were analyzed by Affymetrix MiRNA
QC tool and Genespring V 14.5 software (Agilent, Palo Alto, CA) using Robust Multichip Average. These studies
were performed at Cancer Genomics Laboratory of the Thomas Jefferson University. Heat map was generated
from the list of differentially expressed miRNAs, which was loaded into Ingenuity Pathway Analysis (IPA) 8.0
software (Ingenuity Systems, Redwood City, CA) (http://www.ingenuity.com) for biological network and functional analyses.

Validation of differentially regulated miRNA from genome-wide microarray by quantitative
real-time PCR (qPCR). RNA samples (n = 4 rats) were used for each set of SMCs. miRNA RT-PCR was

performed using miR cDNA Synthesis Kit and SYBR Green master mix RT-PCR Kit (Promega, Madison, WI).
Specific primers to rat miRNAs were designed and synthesized by Qiagen (Qiagen Inc., Valencia, CA). qPCR Ct
values were plotted using GraphPad Prism software and results were normalized against U6B RNA.

Transfection of miRNA and anti-miRNA-139-5p.

In vitro transfections of locked nucleic acid (LNA)
miRNA-139-5p and anti-miRNA-139-5p (Exiqon, MA) in SMCs and tissue strips were performed by using
Hiperfect transfection reagent from Qiagen. 100 nM miRNA or 100 nM anti-miRNA was mixed with transfection
reagent in serum free DMEM and added to SMCs and tissue strips. SMCs were incubated for 72 h and tissue strips
for 48 h, to study the proteomic and functional changes respectively.

Western blot (WB) analysis. The IAS SMCs and tissue lysates were subjected to WB analysis for protein
expression analysis as described previously13. Briefly, total protein from each sample was separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride
membranes (Millipore, Bedford, MA). The membranes were subjected to immunoblot analysis using antibodies
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA) and immunoreactivities to proteins relative to GAPDH
were determined as described previously40, 41.
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Immunocytochemical (ICC) analysis. Using IAS SMCs, ICC was performed at the basal state, for RhoA,

ROCK2, p-MYPT1 and p-MLC20 as described previously13. The nuclei were stained with DAPI. The images
were captured as single acquisitions using Nikon 80i microscope. Images were imported into Image J (National
Institutes of Health) for quantification. Average fluorescence intensity from single cell was calculated by randomly
selecting five different areas of 5 μm2 around the cytoplasm, excluding nuclear area. These values were averaged
and used as n = 1. The above process was repeated for 40 cells at random and calculated as means ± s.e.m. To get
intensity per unit area average intensity was divided by the total area selected for calculating the intensity. Texas
red-conjugated IgGs from mouse, goat and rabbit were used as background fluorescence intensity controls.

Force measurement.

The smooth muscle strips (~1 × 10 mm) prepared from the circular smooth muscle layer of the IAS were used for the force experiments as described previously41. Strips were transfected with
miRNA-139-5p as per29. Briefly, the IAS tissue strips were transferred into 2-ml muscle baths containing KPS
that was continuously perfused with carbogen (95% O2 + 5% CO2). The composition of KPS was as follows
(mM): 118.07 NaCl, 4.69 KCl, 2.52 CaCl2, 1.16 MgSO4, 1.01 NaH2PO4, 25 NaHCO3, and 11.1 glucose. The isometric force was recorded using force transducers (FORT10, WPI, 108 Sarasota, FL). Initially, the strips were
stretched using 1.0 g of tension, after which they were allowed to equilibrate for at least 60 min, during which
time they were repeatedly washed with fresh KPS every 20 min. All force data were monitored using Chart
4.1.2 via a PowerLab/8SP data-acquisition system (ADInstruments, Colorado Springs, CO)41. The spontaneously developed basal IAS tone, and its maximal increase and decrease were calculated with reference to the
responses to bethanechol (100 µM), and 0 Ca2+ respectively, in the beginning and at the end of each experiment.
Concentration-response curves (CRC) for thromboxane A2 analog U46619 (1 nM to 1 µM), and single concentration contractile response for U46619 (1 µM) were examined in the muscle strips pretreated for 48 h with scrambled miRNA (control), and miRNA-139-5p before and after anti-miRNA-139-5p.

Magnetic twisting cytometry (MTC). Individual SMCs contraction was measured directly using MTC,
which monitors dynamic changes in cell stiffness as described previously42. In brief, a functionalized microbead
bound to an adherent cell is first magnetized horizontally and then twisted in a vertically aligned homogenous magnetic field (20 Gauss). Here, lateral bead displacement in response to the resulting oscillatory torque
is detected via a charge-coupled device camera (Hamamatsu Orca AG) attached to an inverted optical microscope, with an accuracy of 5 nm using an intensity-weighted center-of-mass algorithm43. The ratio of specific
torque to lateral bead displacements is then taken as a measure of the complex cell stiffness in units of Pascal per
nm (Pa/nm). The cell stiffness was measured in each cell and, unless otherwise stated, represented as geometric
mean ± s.e.m.42, 43. The cells for these studies were obtained from discarded human tissues in accordance with the
studies approved by Thomas Jefferson University IRB and based on use of deidentified, discarded tissues were
judged to be Not Human Subjects Research.
Statistical analyses. qPCR data for miRNA was replicated in four rats in different experiments. Comparison
between 2 groups was made using the 2-tailed Student’s t test; and comparison between multiple groups was made
using one-way ANOVA using GraphPad Prism 5.0. Data were presented as the mean ± s.e.m.

Results

Differential miRNA expression in tonic vs. phasic SMCs. Genome-wide expression profiles via
microarray on the miRNA from rat IAS, RSM, ASM SMCs were assessed by employing Affymetrix rat Gene
Chip miRNA 1.0 as described previously29. The miRNA microarray data were deposited in the Gene Expression
Omnibus (GEO) database that are accessible at the following link: http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE90981.
Rat IAS (purely tonic) served as control or reference point to determine up- and down-regulation of these
gene transcripts in the RSM (a mixture of tonic and phasic) and ASM (purely phasic) smooth muscle phenotypes.
Only the miRNAs with noticeable gradient between different SMCs following the trend of ASM > RSM > IAS
were presented as a heat map and dendrogram (Fig. 1A). miRNAs showing striking differences between different
phenotypic SMCs following the above trend were plotted as a line graph (Fig. 1B). Among different miRNAs,
only nine miRNAs met these criteria, and further scrutiny revealed that miRNA-139-5p was the most differentially expressed with highest expression in the ASM > RSM > IAS SMCs. qPCR studies validated this trend of
miRNA-139-5p for its significantly differential expression (*p < 0.05; n = 4; Fig. 1C).
miRNA-139-5p targets in SMCs as shown by IPA. Possible targets of miRNA-139-5p were identified by
IPA analysis as described previously26, 29 (Fig. 2). According to previously published studies, one of the direct targets of miRNA-139-5p in humans was identified to be ROCK235, 36, 44, 45. Differential expression of miRNA-139-5p
identified above via miRNA microarray and qPCR data (Fig. 1) was further validated using immunoblot and
immunofluorescence analyses for Rho kinase and its downstream signaling molecules. To further confirm the
functional validity of these data, we monitored smooth muscle force in the IAS and single-cell contractility via
MTC. These studies employed the approaches of overexpression and knockdown of miRNA-139-5p using selective oligomer and anti-miRNA-139-5p, respectively.
Effect of miRNA-139-5p overexpression on RhoA/ROCK pathway. Transfection of rat IAS
SMCs with miRNA-139-5p oligonucleotide (for 72 h) caused a significant decrease in the basal expression levels of RhoA/ROCK2, p-MYPT1, and p-MLC20 as determined via immunoblot (*p < 0.05; n = 4; Fig. 3A,B). It
is noteworthy that, in contrast with the regulation of ROCK2, miRNA-139-5p caused no significant decrease
in the expression of ROCK1 (p > 0.05; n = 4), suggesting the specificity of miRNA-139-5p targeting ROCK2.
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Figure 1. miRNA microarray data and its validation via qPCR. (A) Microarray analysis heat map of
microRNAs isolated form rat IAS, RSM and ASM SMCs. Nine miRNAs shown in the heat map follow the
gradient trend of ASM > RSM > IAS. (B) Graph showing that miRNA microarray identified nine differentially
expressed miRNAs in an ascending gradient manner from the purely tonic, mixture of tonic and phasic to the
purely phasic SMCs as IAS > RSM > ASM. The IAS represents tonic, while RSM and ASM represent semi tonic
and purely phasic smooth muscles, respectively. Among nine differentially expressed miRNAs, miRNA-139-5p
is the most differentially expressed, with ~4-fold higher expression in the ASM vs. the IAS. (C) qPCR analysis
graph showing relative expression calculated by using the equation: Δ Ct = Ct miRNA-Ct (RNU6B) and 2^(−
ΔΔCT) = 2^(−ΔCt IAS, RSM, ASM−ΔCt IAS) confirms the highest expression of miRNA-139-5p in the ASM
vs. the IAS SMCs with pattern similar to that in the differential miRNA microarray (*p < 0.05; n = 4).

Transfection experiments using immunocytochemical studies followed by immunofluorescence analysis also
validated the above notion that miRNA-139-p significantly (*p < 0.05; n = 4; Fig. 4) decreases the expression
of RhoA/ROCK2, p-MYPT1, and p-MLC20 in the IAS SMCs as compared to the control cells transfected with
scrambled miRNA. Figure 3C depicts a model showing miRNA-139-5p associated attenuation of RhoA/ROCK2
signaling leading to decreases in p-MYPT1 and p-MLC20.

Effect of miRNA-139-5p and anti-miRNA-139-5p on the basal tone.

Considering the role of Rho
kinase in maintaining basal IAS SM tone11, 14, 18, we investigated whether the decreased expression of ROCK2
by miRNA-139-5p is responsible for the changes in the basal tone. Data showed that transfection of IAS muscle
strips with miRNA-139-5p (100 nM for 48 h) significantly decreased (33 ± 7%; p < 0.05; n = 4; Fig. 5A) basal tone.
The effect of miRNA-139-5p overexpression was found to be selective given anti-miRNA-139-5p significantly
(*p < 0.05; Fig. 5A) reversed the inhibitory effect of miRNA-139-5p on the IAS tone. Of equal significance, in
contrast with the effect of miRNA-139-5p, reducing expression of miRNA-139-5p using anti-miRNA-139-5p had
the opposite effect, causing an increase in the IAS tone.

Effect of miRNA-139-5p and anti-miRNA-139-5p on ROCK activator U46619-induced increase
in IAS tone. Transfection of the IAS smooth muscle strips with miRNA-139-5p caused a significant rightward shift in the U46619 CRC (*p < 0.05; n = 4; Fig. 5B). Anti-miRNA-139-5p significantly reversed this effect
of miRNA-139-5p (*p < 0.05; n = 4). U46619 CRC following the combination of the miRNA and anti-miRNA139-5p was not significantly different as compared to control (p > 0.05; n = 4; Fig. 5B). These data show the
specificity of both miRNA and anti-miRNA-139-5p. Moreover, anti-miRNA-139-5p expression itself caused a
significant leftward shift in the U46619 CRC (*p < 0.05; n = 4; Fig. 5B).
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Figure 2. Ingenuity pathway analysis (IPA) showing ROCK2 as one of the direct targets of miRNA-139-5p.
miRNA microarray data was subjected to ingenuity pathway analysis (IPA) and various validated targets of miR139-5p from the literature were plotted as an Interactome. The analysis shows that human ROCK2 is one of the
direct targets of miR-139-5p as it has a direct miR-139-5p binding site at its 3′UTR. Some of the other validated
targets mentioned in literature, which may also be down-regulated in tonic smooth muscles are given in this
interactome.

Influence of miRNA-139-5p and anti-miRNA-139-5p on kinetics and amplitude of peak
increase in IAS tone by U46619. For these experiments, we determined the time-course effect of miRNA

and anti-miRNA-139-5p, alone and in combination, on U46619 (1 µM)-induced increase in the IAS tone over
a period of 20 min. Data revealed that miRNA-139-5p inhibited the velocity (shown by the rightward shift in
the time-course curve) of fast contraction, and the maximal contraction produced by U46619 (*p < 0.05; n = 4;
Fig. 5C). The rightward shift in the velocity following miRNA-139-5p, and its reversal following anti-miRNA was
shown by the regression lines. Importantly, ant-miRNA-139-5p had an effect opposite to that of miRNA-139-5p,
i.e. it caused a significant increase in the amplitude of maximal contraction with a leftward shift in the U46619
response kinetics during initial phase of contraction (*p < 0.05; n = 4).

Effect of miRNA-139-5p transfection on the speed of relaxation with 0 Ca2+ and of redevelopment of IAS tone following replenishment with normal Ca2+. Since RhoA/ROCK plays an important

role in the development of IAS tone and in the fibroelastic properties11, 14, 18, 41, 46, it was considered important to
determine whether miRNA-139-5p by suppressing ROCK2 affects the speed of IAS relaxation and genesis of IAS
tone following 0 Ca2+, and Ca2+ replenishment, respectively. Data revealed that miRNA-139-5p causes a significant
decrease in the speed of both relaxation following 0 Ca2+ (*p < 0.05; n = 4; Fig. 6A) and of redevelopment of the
tone following Ca2+ replenishment (*p < 0.05; n = 4; Fig. 6B). Both of these miRNA-139-5p-affected events were
significantly reversed by anti-miRNA-139-5p (*p < 0.05). Collectively, these data examining the effect in the basal
and ROCK-activated states, and kinetic analyses of the IAS tone suggest that miRNA-139-5p by suppressing ROCK2
expression produces inhibitory effects in the basal tone and on the fibroelastic properties of the smooth muscle.

Effect of miRNA-139-5p on basal and U46619-induced stiffness using direct IAS SMC contractility assay via MTC. To further ascertain the mechanism by which miRNA-139-5p regulates the basal tone

in IAS, we used MTC and measured dynamic changes in the stiffness of human IAS SMCs as indices of single-cell
contraction as described previously42. This approach eliminates any potential contamination with other unrecognized mechanisms that may be operative in the IAS smooth muscle preparation. Here, magnetic particles attached
to the cytoskeleton of SMCs by a peptide linker provide a highly quantitative measurement of cytoskeletal stiffness of the living cells at the single-cell resolution. Consistent with the data in the smooth muscle strips, MTC
data demonstrate that transfection of human IAS SMCs with ROCK2 siRNA and miRNA-139-5p decreased baseline cell stiffness (basal tone) (Fig. 7A). Conversely, transfection of human IAS SMCs with anti-miRNA-139-5p
increased basal tone, which was attenuated by co-transfection with miRNA-139-5p (Fig. 7A). Most strikingly,
these SMCs transfected with anti-miRNA-139-5p showed faster and greater cell stiffening responses to 100 nM
U46619, and this single-cell contraction was inhibited by miRNA-139-5p (Fig. 7B). In addition, since both basal
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Figure 3. Effect of miRNA-139-5p overexpression on RhoA/ROCK machinery in IAS SMCs. (A) Western
blot data showing that miRNA-139-5p overexpression in the IAS SMCs decreases the expression of RhoA/
ROCK signal transduction machinery proteins which is selectively blocked by the anti-miRNA-139-5p. (A)
(upper portion). Western blots comparing the expression levels of RhoA, ROCK1, and ROCK2 before and
after miRNA-139-5p, anti-miRNA-139-5p alone, and following miRNA-139-5p + anti-miRNA-139-5p. The
lower portion of the panel provides the corresponding quantitative data showing that miRNA-139-5p causes
significant (*p < 0.05) downregulation of RhoA and ROCK2 without any significant (p > 0.05) effect on the
levels of ROCK1. Conversely, anti-miRNA-139-5p by itself causes significant upregulation of RhoA and ROCK2
(*p < 0.05). (As indicated, RhoA, ROCK1, and ROCK2 expressions were compared with GAPDH.) (B) (upper
portion).Western blots comparing the expression levels of p-MYPT1and p-MLC20, before and after miRNA139-5p, anti-miRNA-139-5p alone, and following miRNA-139-5p + anti-miRNA-139-5p. The lower portion of
this panel provides the quantitative data showing that miRNA-139-5p significantly (*p < 0.05) downregulates,
while anti-miRNA-139-5p causes significant (*p < 0.05) upregulation of p-MYPT1 and p-MLC20. (As shown,
p-MYPT1, and p-MLC20 expressions were compared with MYPT1 and MLC20, respectively.) (C) Model
representing the effect of miRNA-139-5p on RhoA/ROCK2 signaling cascade. The IAS smooth muscle is
characterized by upregulated RhoA/ROCK signaling which may be either constitutively active or GPCRactivated. Data suggest that higher levels of miRNA-139-5p in the IAS attenuate ROCK2 expression, which in
turn leads to activation of MLCP (via decrease in p-MYPT1), and decrease in p-MLC20 and basal tone.

Figure 4. Immunocytochemistry data before and after miRNA-139-5p. (A) Immunocytochemical images
showing expression of RhoA, ROCK2, p-MYPT1, and p-MLC20 following transfection of IAS SMCs with
miRNA-139-5p. (B) Quantitative data showing significant (*p < 0.05) downregulation of immunofluorescence
intensity of RhoA, ROCK2, p-MYPT1, and p-MLC20 in the IAS SMCs following transfection with miRNA139-5p as compared with controls (cells treated with scrambled miRNA). BG = background.
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Figure 5. Effect of miRNA- and anti-miRNA-139-5p. (A) miRNA-139-5p (100 nM) produces significant
(*p < 0.05; n = 5) decrease in the IAS tone, as compared with scrambled miRNA (control), which is significantly
blocked by pre-treatment with 100 nM antagomir (*p < 0.05; n = 5). Conversely, 100 nM antagomir by itself
significantly (*p < 0.05; n = 4) increases the IAS tone as compared to control. (B) miRNA-139-5p significantly
shifts U46619 CRC causing an increase in the IAS tone towards right (*p < 0.05; n = 6–8), which is attenuated
by the antagomir. In contrast, the antagomir causes a significant shift in the control CRC to left (p > 0.05;
n = 6–8). (C) Time course data with U46619 (1 μM) before and after miRNA-139-5p show a significant
(*p < 0.05) decrease in the maximal increase in the IAS tone and increase in the time taken to achieve it
following miRNA-139-5p transfection. The above described effect of miRNA-139-5p is significantly (*p < 0.05)
attenuated by the pre-transfection of the smooth muscles with anti-miRNA-139-5p. Conversely, anti-miRNA139-5p significantly (*p < 0.05) increases the maximal effect and produces left-ward shift in time-course of
U46619-induced contraction. Changes in the shifts in the kinetic velocities following U46619 are shown by the
regression analyses with dashed lines.

Figure 6. Effect of miRNA- and anti-miRNA-139-5p on IAS kinetics. (A,B) Graphs showing rate of relaxation
(A) and of recovery (B) of IAS tone following 0 Ca2+ and normal Ca2+ replenishment, respectively, following
transfection of the smooth muscle strips. miRNA-139-5p significantly (*p < 0.05) decreases the rates of
relaxation and of recovery of the IAS tone which are significantly reversed by anti-miRNA-139-5p pretreatment (*p < 0.05; n = 6–8).
IAS tone11–14, 16, 18 and response to U4661929, 47, which are critically dependent on RhoA/ROCK activation, were
attenuated by ROCK2 siRNA, suggest that miRNA-139-5p exerts its effects via ROCK2 suppression.

Discussion

The current study examining the phenotypic smooth muscles and cells from IAS (purely tonic), RSM (semi tonic)
and the ASM (purely phasic), demonstrate that the expression levels of miRNA-139-5p correlate inversely with
those of tone and ROCK2 expression. In addition, these data for the first time show that miRNA-139-5p negatively regulates the tonic smooth muscle function via suppression of RhoA/ROCK2. Previously published studies
have reported a significant gradient in the expression levels of RhoA/ROCK highest in the IAS and lowest in
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Figure 7. MTC data showing the effect of miRNA- and anti-miRNA-139-5p. (A) Baseline cell stiffness of
individual IAS SMCs before and after 72 h transfection with ROCK2 siRNA, miRNA-139-5p, anti-miRNA139-5p (inhibitor), and miRNA-139-5p plus the inhibitor. SMCs transfected with ROCK2 siRNA and miRNA139-p showed decreases in baseline cell stiffness (basal tone) while cells transfected with anti-miRNA-139-5p
showed increases in basal tone. Increased basal tone in response to anti-miRNA-139-5p was attenuated
with co-transfection with miRNA-139-5p. Data are presented as Mean ± s.e.m. (n = 89–149 individual cell
measurements). (B) Dynamic changes the stiffness of IAS SMCs in response to 100 nM U46619. Consistent with
the rat smooth muscle data, anti-miRNA-139-5p causes faster and greater cell stiffening in response to U46619.

the ASM in correlation with the levels of tonicity in the smooth muscle as follows IAS > RSM > ASM11–14, 16, 18.
Collectively, these data suggest an important role of miRNA-139-5p in the genesis of basal tone in the IAS and
lack of tone in the purely phasic smooth muscles such as the ASM.
It is well known that miRNAs suppress the expression of multiple genes via binding to the complimentary
sequence to the mRNA. Similar data has been obtained in the gastrointestinal smooth muscle phenotypes both
in animals and humans26–28. Additionally, miRNAs have been shown to be expressed in a tissue-specific manner, suggesting their role in maintaining smooth muscle-specific genotypic and phenotypic characteristics34,
48, 49
. Recent studies from our laboratory have shown that aging leads to changes in certain miRNAs such as
miRNA-133a that affect IAS tone by targeting RhoA/ROCK signal transduction cascade critical for the basal IAS
tone29. Similar data were obtained in murine stomach where increase in miRNA-133a was shown to downregulate RhoA and decrease in the smooth muscle contractility30. However, the role of miRNAs in the regulation of
phenotypic tonic vs. phasic smooth muscles has not been examined before.
Herein, we performed microarray analysis to screen differential expression of miRNAs in the SMCs from IAS,
RSM and ASM. Among nine miRNAs, we observed a graded and most differential decrease in miRNA-139-5p
expression ASM > RSM > IAS. The findings of microarray differential expression were further confirmed via
qPCR analyses. miRNA-139-5p encoded within the second intron of the phosphodiesterase 2 A (PDE2A) gene
has been shown to be located on chromosome 1135. Of further importance, miRNA-139-5p has been shown to be
a potential tumor suppressor in humans by targeting ROCK235, 36, 44, 45.
Targeting of ROCK2 by miRNA-139-5p was further verified by our current IPA as shown in Fig. 2. In addition, present data using qPCR, WB, ICC, and functional data in the IAS tone, and direct contractility assays
using MTC, following overexpression and knockdown of miRNA-139-p suggest that miRNA-139-5p negatively
regulates the IAS tone via ROCK2.
Our immunoblot and ICC analysis also revealed downregulation of RhoA, ROCK2, pMYPT1, and p-MLC20
proteins in miRNA-139-transfected cells, speculatively via targeting ROCK2.
To determine the effect of miRNA-139-5p on smooth muscle function, we overexpressed or knocked down
miRNA-139-5p in IAS smooth muscle strips (for force experiments), and SMCs (for MTC experiments monitoring direct contraction assay of SMCs) by transfecting them with synthetic miRNA-139-5p and anti-miRNA139-5p, respectively.
The smooth muscle transfection experiments with miRNA-139-5p reveal a decrease in the basal tone,
and attenuation of ROCK activator U46619-induced an increase in the tone. The blockade of these effects by
anti-miRNA-139-5p demonstrates the selectivity of actions of miRNA-139-5p. Of added significance the
anti-miRNA-139-5p caused an augmentation in basal tone and its increase following U46619 provide further
credence to the hypothesis that miRNA-139-5p plays an important role in the maintenance of tonicity in the IAS
via RhoA/ROCK signaling.
Additional experiments show that miRNA-139-5p decreases the speeds of relaxation and recovery to the basal
IAS tone following 0 Ca2+ and normal Ca2+ respectively. Previously published studies have shown that the fibroelastic properties responsible for the speeds of relaxation and recovery of the basal IAS tone are dependent upon
RhoA/ROCK machinery41, 46, 50. The present study’s MTC experiments complement the above functional studies.
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The MTC data show that the effects of miRNA-139-5p are similar to those of ROCK2-siRNA in decreasing the
basal stiffness of the IAS SMCs and their contractility (measured as maximal increase in amplitude and shifts in
the kinetics of initial fast phase of contraction) in response to RhoA/ROCK activator U46619. These data further
support the concept that miRNA-139-5p regulates the IAS tone and smooth muscle phenotype differentiation via
RhoA/ROCK.
Earlier studies using cancer cell lines35, 36, 44, 45 have shown that miRNA-139-5p targets ROCK2 directly in
humans. Those data are in agreement with our hypothesis that miRNA-139-5p regulates specific functioning
of tonic vs. phasic phenotypic smooth muscles by regulating ROCK2. Since present studies did not determine
a direct target site of miR-139-5p in rat ROCK2 UTR previously established in humans, an indirect effect via
some other intermediary proteins cannot be ruled out and deserves further investigation. For example, studies in different systems have shown the involvement of IGF-1/insulin-p42/p44MAPKp90RSK-eFF2 signaling axis in the regulation of ROCK2 expression35, 51. In addition, involvement of other intermediary pathways
or targets of miRNA-139-5p such as TGF-β, Wnt, MAPK, and PI3K reported to inhibit RhoA/ROCK35 and
microRNA-mediated G protein-coupled receptors (GPCR) crosstalk52, require further investigations.
In summary, our studies suggest that miRNA-139-5p plays a significant role in the functional phenotypic
smooth muscles by repressing RhoA/ROCK pathway in the SMCs, and that its low expression in the IAS may
contribute to the basal tone. Present data suggest an important role of miRNA-139-5p in determining the levels
of smooth muscle tone and phenotype differentiation. Such data may lead to new inroads in our understanding
of the pathophysiology and therapeutic targeting in the rectoanal motility disorders associated with the IAS tone.
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